• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自病变组织的 AA 淀粉样纤维在结构上与体外形成的 SAA 纤维不同。

AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.

机构信息

Institute of Protein Biochemistry, Ulm University, Ulm, Germany.

出版信息

Nat Commun. 2021 Feb 12;12(1):1013. doi: 10.1038/s41467-021-21129-z.

DOI:10.1038/s41467-021-21129-z
PMID:33579941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7881110/
Abstract

Systemic AA amyloidosis is a world-wide occurring protein misfolding disease of humans and animals. It arises from the formation of amyloid fibrils from serum amyloid A (SAA) protein. Using cryo electron microscopy we here show that amyloid fibrils which were purified from AA amyloidotic mice are structurally different from fibrils formed from recombinant SAA protein in vitro. Ex vivo amyloid fibrils consist of fibril proteins that contain more residues within their ordered parts and possess a higher β-sheet content than in vitro fibril proteins. They are also more resistant to proteolysis than their in vitro formed counterparts. These data suggest that pathogenic amyloid fibrils may originate from proteolytic selection, allowing specific fibril morphologies to proliferate and to cause damage to the surrounding tissue.

摘要

系统性 AA 淀粉样变性是一种在人类和动物中广泛存在的蛋白质错误折叠疾病。它是由血清淀粉样 A(SAA)蛋白形成淀粉样纤维引起的。本文使用低温电子显微镜显示,从 AA 淀粉样变性小鼠中纯化的淀粉样纤维在结构上不同于体外重组 SAA 蛋白形成的纤维。在体淀粉样纤维由纤维蛋白组成,其有序部分含有更多的残基,β-折叠含量高于体外纤维蛋白。它们也比体外形成的纤维蛋白更能抵抗蛋白水解。这些数据表明,致病性淀粉样纤维可能源于蛋白水解选择,允许特定的纤维形态增殖,并对周围组织造成损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/7309a82d1c06/41467_2021_21129_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/6037eb5745f3/41467_2021_21129_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/92b53d44adf6/41467_2021_21129_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/90d4c27ab6e5/41467_2021_21129_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/1f4799289025/41467_2021_21129_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/473b3d7261c3/41467_2021_21129_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/7309a82d1c06/41467_2021_21129_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/6037eb5745f3/41467_2021_21129_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/92b53d44adf6/41467_2021_21129_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/90d4c27ab6e5/41467_2021_21129_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/1f4799289025/41467_2021_21129_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/473b3d7261c3/41467_2021_21129_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a399/7881110/7309a82d1c06/41467_2021_21129_Fig6_HTML.jpg

相似文献

1
AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.来自病变组织的 AA 淀粉样纤维在结构上与体外形成的 SAA 纤维不同。
Nat Commun. 2021 Feb 12;12(1):1013. doi: 10.1038/s41467-021-21129-z.
2
Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.Cryo-EM 纤维结构来自系统性 AA 淀粉样变性,揭示了病理性淀粉样蛋白的物种互补性。
Nat Commun. 2019 Mar 7;10(1):1104. doi: 10.1038/s41467-019-09033-z.
3
Cryo-EM demonstrates the in vitro proliferation of an ex vivo amyloid fibril morphology by seeding.低温电子显微镜显示通过接种使体外淀粉样纤维形态的体外增殖。
Nat Commun. 2022 Jan 10;13(1):85. doi: 10.1038/s41467-021-27688-5.
4
Methods to study the structure of misfolded protein states in systemic amyloidosis.研究系统性淀粉样变性中错误折叠蛋白状态结构的方法。
Biochem Soc Trans. 2021 Apr 30;49(2):977-985. doi: 10.1042/BST20201022.
5
Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis.人溶菌酶抑制系统性 AA 淀粉样变性的血清淀粉样蛋白 A 纤维形成。
Amyloid. 2023 Dec;30(4):424-433. doi: 10.1080/13506129.2023.2232518. Epub 2023 Jul 11.
6
Transmission of systemic AA amyloidosis in animals.动物全身性AA淀粉样变性的传播。
Vet Pathol. 2014 Mar;51(2):363-71. doi: 10.1177/0300985813511128. Epub 2013 Nov 26.
7
Amyloid fibril structure from the vascular variant of systemic AA amyloidosis.系统性 AA 淀粉样变血管变异型的淀粉样纤维结构。
Nat Commun. 2022 Nov 25;13(1):7261. doi: 10.1038/s41467-022-34636-4.
8
Cryo-EM structure of ex vivo fibrils associated with extreme AA amyloidosis prevalence in a cat shelter.在一个猫咪收容所中,与极高 AA 淀粉样变性患病率相关的体外原纤维的冷冻电镜结构。
Nat Commun. 2022 Nov 17;13(1):7041. doi: 10.1038/s41467-022-34743-2.
9
Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.通过各种均一的淀粉样纤维和类淀粉样合成肽诱导小鼠AA淀粉样变性。
Scand J Immunol. 2007 Nov;66(5):495-500. doi: 10.1111/j.1365-3083.2007.02005.x.
10
Protease resistance of amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies.淀粉样纤维的蛋白酶抗性意味着与疾病相关的纤维形态的蛋白水解选择。
Amyloid. 2021 Dec;28(4):243-251. doi: 10.1080/13506129.2021.1960501. Epub 2021 Aug 2.

引用本文的文献

1
Identification and characterization of spontaneous AA amyloidosis in CD-1 mice used in toxicity studies: implications of SAA1 and SAA2 copy number variations.用于毒性研究的CD-1小鼠自发性AA淀粉样变性的鉴定与特征分析:血清淀粉样蛋白A1和血清淀粉样蛋白A2拷贝数变异的影响
J Toxicol Pathol. 2025 Jan;38(1):69-82. doi: 10.1293/tox.2024-0070. Epub 2024 Nov 13.
2
Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis.遗传性淀粉样变性中溶菌酶衍生的淀粉样纤维的冷冻电镜结构。
Nat Commun. 2024 Nov 7;15(1):9648. doi: 10.1038/s41467-024-54091-7.
3
Real-Time 3D Imaging and Inhibition Analysis of Human Serum Amyloid A Aggregations Using Quantum Dots.

本文引用的文献

1
Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis.冷冻电镜揭示了系统性 AL 淀粉样变性患者来源的淀粉样纤维中的结构断裂。
Nat Commun. 2021 Feb 8;12(1):875. doi: 10.1038/s41467-021-21126-2.
2
Comparative study of the stabilities of synthetic and natural transthyretin amyloid fibrils.合成和天然转甲状腺素蛋白淀粉样纤维稳定性的比较研究。
J Biol Chem. 2020 Aug 14;295(33):11379-11387. doi: 10.1074/jbc.RA120.014026. Epub 2020 Jun 22.
3
Structures of α-synuclein filaments from multiple system atrophy.
利用量子点实时成像和抑制分析人血清淀粉样蛋白 A 聚集
Int J Mol Sci. 2024 Oct 16;25(20):11128. doi: 10.3390/ijms252011128.
4
Water-protein interactions as a driver of phase separation, biology, and disease.水-蛋白质相互作用作为相分离、生物学及疾病的驱动因素
Biophys J. 2024 Nov 19;123(22):3859-3862. doi: 10.1016/j.bpj.2024.10.010. Epub 2024 Oct 15.
5
Hierarchical Protofilament Intertwining Rules the Formation of Mixed-Curvature Amyloid Polymorphs.层次原纤维纠缠规则混合曲率淀粉样纤维多形体的形成。
Adv Sci (Weinh). 2024 Aug;11(32):e2402740. doi: 10.1002/advs.202402740. Epub 2024 Jun 20.
6
AA Amyloidosis: A Contemporary View.淀粉样变病:当代观点。
Curr Rheumatol Rep. 2024 Jul;26(7):248-259. doi: 10.1007/s11926-024-01147-8. Epub 2024 Apr 3.
7
Structural insight into CsgA amyloid fibril assembly.CsgA 淀粉样纤维组装的结构见解。
mBio. 2024 Apr 10;15(4):e0041924. doi: 10.1128/mbio.00419-24. Epub 2024 Mar 19.
8
Molecular Crowding: The History and Development of a Scientific Paradigm.分子拥挤:一种科学范式的历史与发展
Chem Rev. 2024 Mar 27;124(6):3186-3219. doi: 10.1021/acs.chemrev.3c00615. Epub 2024 Mar 11.
9
Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases.错误折叠的蛋白质寡聚物:形成机制、细胞毒性作用以及针对蛋白质错误折叠疾病的药理学方法。
Mol Neurodegener. 2024 Feb 20;19(1):20. doi: 10.1186/s13024-023-00651-2.
10
Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils.低温电子显微镜观察到多态性 TDP-43 淀粉样纤维的淀粉样关键结构。
Nat Commun. 2024 Jan 12;15(1):486. doi: 10.1038/s41467-023-44489-0.
多系统萎缩中α-突触核蛋白丝的结构。
Nature. 2020 Sep;585(7825):464-469. doi: 10.1038/s41586-020-2317-6. Epub 2020 May 27.
4
Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.遗传性转甲状腺素淀粉样变性患者源性转甲状腺素蛋白衍生淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Nov 1;10(1):5008. doi: 10.1038/s41467-019-13038-z.
5
Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue.从阿尔茨海默病脑组织中纯化的 Aβ 淀粉样纤维的冷冻电镜结构和多态性。
Nat Commun. 2019 Oct 29;10(1):4760. doi: 10.1038/s41467-019-12683-8.
6
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix.利用 X 射线、中子和电子进行高分子结构测定: Phenix 的最新进展。
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877. doi: 10.1107/S2059798319011471. Epub 2019 Oct 2.
7
Morphological and primary structural consistency of fibrils from different AA patients (common variant).不同 AA 患者(常见变异型)的纤维的形态和初级结构一致性。
Amyloid. 2019 Sep;26(3):164-170. doi: 10.1080/13506129.2019.1628015. Epub 2019 Jun 26.
8
Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules.慢性创伤性脑病中的新型 tau 丝折叠包裹疏水分子。
Nature. 2019 Apr;568(7752):420-423. doi: 10.1038/s41586-019-1026-5. Epub 2019 Mar 20.
9
Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.系统性轻链淀粉样变性患者来源的轻链衍生淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Mar 20;10(1):1103. doi: 10.1038/s41467-019-09032-0.
10
Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.免疫球蛋白轻链 AL 淀粉样变性患者心脏淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Mar 20;10(1):1269. doi: 10.1038/s41467-019-09133-w.